Visible Genomics offers advanced genetic testing for Age-Related Macular Degeneration (AMD), helping individuals understand their genetic risk and plan effective treatment. By identifying unique genetic markers, the test provides a personalized risk profile, enabling early detection, tailored treatment plans, and informed lifestyle choices to slow disease progression. The process involves a simple sample collection, advanced genetic analysis, and a comprehensive report with actionable insights.